(E/Z)-ZINC09659342
CAS No. 591726-26-0
(E/Z)-ZINC09659342( —— )
Catalog No. M29007 CAS No. 591726-26-0
(E/Z)-ZINC09659342 is an inhibitor of Lbc-Rho A interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 107 | In Stock |
|
| 5MG | 98 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 264 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 492 | In Stock |
|
| 200MG | 643 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(E/Z)-ZINC09659342
-
NoteResearch use only, not for human use.
-
Brief Description(E/Z)-ZINC09659342 is an inhibitor of Lbc-Rho A interaction.
-
Description(E/Z)-ZINC09659342 is an inhibitor of Lbc-Rho A interaction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetRho
-
RecptorRho
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number591726-26-0
-
Formula Weight440.37
-
Molecular FormulaC23H15F3N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 50 mg/mL (113.54 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CCG-100602
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM).
-
CCG-1423
CCG-1423 is a specific RhoA pathway inhibitor, which inhibits SRF-mediated transcription.
-
AZA1
AZA1 (Rac1/Cdc42-IN-1) is a potent dual inhibitor of Rac1 and Cdc42. AZA1 induced apoptosis of prostate cancer cells and inhibited cell proliferation, migration and invasion.
Cart
sales@molnova.com